Namvar, A., Bolhassani, A., Javadi, G., & Noormohammadi, Z. (2019). In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine. Nature Portfolio.
Cita Chicago Style (17a ed.)Namvar, Ali, Azam Bolhassani, Gholamreza Javadi, y Zahra Noormohammadi. In Silico/In Vivo Analysis of High-risk Papillomavirus L1 and L2 Conserved Sequences for Development of Cross-subtype Prophylactic Vaccine. Nature Portfolio, 2019.
Cita MLA (8a ed.)Namvar, Ali, et al. In Silico/In Vivo Analysis of High-risk Papillomavirus L1 and L2 Conserved Sequences for Development of Cross-subtype Prophylactic Vaccine. Nature Portfolio, 2019.
Precaución: Estas citas no son 100% exactas.